Your browser doesn't support javascript.
loading
Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial.
Held, Claes; White, Harvey D; Stewart, Ralph A H; Davies, Richard; Sampson, Shani; Chiswell, Karen; Silverstein, Adam; Lopes, Renato D; Heldestad, Ulrika; Budaj, Andrzej; Mahaffey, Kenneth W; Wallentin, Lars.
Afiliação
  • Held C; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. Electronic address: claes.held@ucr.uu.se.
  • White HD; Green Lane Cardiovascular Service, Auckland City Hospital and University of Auckland, Auckland, New Zealand.
  • Stewart RAH; Green Lane Cardiovascular Service, Auckland City Hospital and University of Auckland, Auckland, New Zealand.
  • Davies R; Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, King of Prussia, PA.
  • Sampson S; Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, King of Prussia, PA.
  • Chiswell K; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.
  • Silverstein A; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.
  • Lopes RD; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.
  • Heldestad U; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
  • Budaj A; Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland.
  • Mahaffey KW; Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
  • Wallentin L; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Am Heart J ; 208: 65-73, 2019 02.
Article em En | MEDLINE | ID: mdl-30572273

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oximas / Benzaldeídos / Doença das Coronárias / Acidente Vascular Cerebral / Inibidores de Fosfolipase A2 / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Revista: Am Heart J Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oximas / Benzaldeídos / Doença das Coronárias / Acidente Vascular Cerebral / Inibidores de Fosfolipase A2 / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Revista: Am Heart J Ano de publicação: 2019 Tipo de documento: Article